Overview
Arjun Balar is an Oncologist in New York, New York. Dr. Balar is rated as an Advanced provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, and Thrombectomy.
His clinical research consists of co-authoring 71 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Memorial Solid Tumor Group
Robert Motzer is an Oncologist in New York, New York. Dr. Motzer is rated as an Elite provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Teratoma of the Mediastinum, Nephrectomy, and Orchiectomy.
Northwell Health Physician Partners Smith Institute For Urology At Lake Success
Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is rated as an Elite provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.
Memorial Solid Tumor Group
Martin Voss is an Oncologist in New York, New York. Dr. Voss is rated as an Elite provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Balar isElite. Learn about Bladder Cancer.
- Urothelial CancerDr. Balar isElite. Learn about Urothelial Cancer.
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Balar isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Familial Prostate CancerDr. Balar isDistinguished. Learn about Familial Prostate Cancer.
- Muscle Invasive Bladder CancerDr. Balar isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Balar isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Balar isDistinguished. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Balar isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Advanced
- Clear Cell SarcomaDr. Balar isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Balar isAdvanced. Learn about Familial Wilms Tumor 2.
- Urachal CancerDr. Balar isAdvanced. Learn about Urachal Cancer.
- Wilms TumorDr. Balar isAdvanced. Learn about Wilms Tumor.
- Experienced
- Adrenal CancerDr. Balar isExperienced. Learn about Adrenal Cancer.
- Adult Soft Tissue SarcomaDr. Balar isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ChoriocarcinomaDr. Balar isExperienced. Learn about Choriocarcinoma.
- Hereditary NeuroblastomaDr. Balar isExperienced. Learn about Hereditary Neuroblastoma.
- Lung CancerDr. Balar isExperienced. Learn about Lung Cancer.
- Lung NodulesDr. Balar isExperienced. Learn about Lung Nodules.
